Objective: To compare the pharmacokinetic profile and bioavailability of budesonide after inhalation from the Clickhaler® dry powder inhaler with the Turbuhaler® as standard. Design: Randomised, ...

Earlier and more sustained treatment of mild asthma improves control of asthma symptoms and reduces the risk of a severe exacerbation, thereby preventing lung function damage according to the results ...

Budesonide (micronized) 90mcg/inh, 180mcg/inh; dry pwd for inhalation. Pulmicort Flexhaler is available as a dry powder for inhalation containing budesonide in the following 2 strengths: 90 mcg and ...

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bj53j9/pulmicort) has announced the addition of the "Pulmicort (Asthma ...

AstraZeneca is giving up on a hard-to-manufacture inhaler. The company will stop making Pulmicort pMDI, a form of the asthma drug delivered through a pressurized inhaler, because of "manufacturing ...

AstraZeneca (AZ) suffered another setback yesterday when a US federal court ruled that a patent for its inhaled steroid drug Pulmicort Respules was invalid. The US District Court for the District of ...

Drugs giant AstraZeneca is ending production of a pressurised metered dose inhaler version of its asthma treatment Pulmicort, which has been developed with technology partner SkyePharma.

AstraZeneca’s Symbicort Turbuhaler (budesonide/formoterol 160/4.5mcg) has been approved in China as an anti-inflammatory reliever to be taken as-needed in response ...

This randomised, double-blind, double-dummy crossover study was designed to compare the pharmacokinetic profile and pulmonary bioavailability of budesonide 1000µg delivered by inhalation as a powder ...